9.32
price up icon1.30%   +0.12
after-market  After Hours:  9.24  -0.08   -0.86%
loading
TriplePoint Venture Growth BDC Corp. stock is currently priced at $9.32, with a 24-hour trading volume of 400.21K. It has seen a +1.30% increased in the last 24 hours and a +0.76% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $9.26 pivot point. If it approaches the $9.35 resistance level, significant changes may occur.
Previous Close:
$9.20
Open:
$9.23
24h Volume:
400.21K
Market Cap:
$352.72M
Revenue:
$-27.07M
Net Income/Loss:
$-39.82M
P/E Ratio:
-13.51
EPS:
-0.69
Net Cash Flow:
$106.15M
1W Performance:
-1.79%
1M Performance:
+0.76%
6M Performance:
-8.27%
1Y Performance:
-5.28%
1D Range:
Value
$9.21
$9.355
52W Range:
Value
$8.88
$12.70

TriplePoint Venture Growth BDC Corp. Stock (TPVG) Company Profile

Name
Name
TriplePoint Venture Growth BDC Corp.
Name
Phone
-
Name
Address
2755 Sand Hill Road, Suite 150, Menlo Park, CA
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-05-01
Name
Latest SEC Filings
Name
TPVG's Discussions on Twitter

TriplePoint Venture Growth BDC Corp. Stock (TPVG) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-23-23 Upgrade Compass Point Sell → Neutral
Aug-03-23 Downgrade Compass Point Neutral → Sell
May-04-23 Downgrade Wells Fargo Overweight → Equal Weight
Dec-20-22 Downgrade Keefe Bruyette Mkt Perform → Underperform
Dec-13-22 Downgrade Piper Sandler Overweight → Neutral
Dec-01-22 Initiated UBS Neutral
Oct-15-21 Downgrade Compass Point Buy → Neutral
Sep-21-21 Upgrade Compass Point Neutral → Buy
Jul-12-21 Initiated Piper Sandler Overweight
May-19-21 Initiated Oppenheimer Perform
Nov-19-20 Resumed JMP Securities Mkt Outperform
May-13-20 Downgrade Compass Point Buy → Neutral
Apr-02-20 Upgrade Compass Point Neutral → Buy
Mar-05-20 Upgrade Ladenburg Thalmann Neutral → Buy
Jan-14-20 Initiated JMP Securities Mkt Outperform
Jul-08-19 Initiated Nomura Buy
May-06-19 Downgrade Compass Point Buy → Neutral
Sep-21-18 Initiated Wells Fargo Outperform
Dec-12-17 Initiated Ladenburg Thalmann Neutral
Nov-28-17 Upgrade Compass Point Neutral → Buy
Aug-29-17 Downgrade Compass Point Buy → Neutral
Aug-25-16 Downgrade Compass Point Buy → Neutral
Jun-29-16 Initiated Compass Point Buy
May-02-16 Initiated Ladenburg Thalmann Buy
View All

TriplePoint Venture Growth BDC Corp. Stock (TPVG) Financials Data

TriplePoint Venture Growth BDC Corp. (TPVG) Revenue 2024

TPVG reported a revenue (TTM) of -$27.07 million for the quarter ending December 31, 2023, a -184.64% decline year-over-year.
loading

TriplePoint Venture Growth BDC Corp. (TPVG) Net Income 2024

TPVG net income (TTM) was -$39.82 million for the quarter ending December 31, 2023, a -98.41% decrease year-over-year.
loading

TriplePoint Venture Growth BDC Corp. (TPVG) Cash Flow 2024

TPVG recorded a free cash flow (TTM) of $106.15 million for the quarter ending December 31, 2023, a +205.21% increase year-over-year.
loading

TriplePoint Venture Growth BDC Corp. (TPVG) Earnings per Share 2024

TPVG earnings per share (TTM) was -$1.12 for the quarter ending December 31, 2023, a -86.67% decline year-over-year.
loading
TriplePoint Venture Growth BDC Corp is a business development company specializing investments in growth stage. It also provides debt financing to venture growth space companies which includes growth capital loans, equipment financings, revolving loans, and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It does not take board seat in the company.
asset_management STT
$75.11
price up icon 0.97%
$112.01
price up icon 0.46%
$136.17
price up icon 3.23%
asset_management AMP
$424.96
price up icon 1.43%
asset_management BK
$57.48
price up icon 0.84%
asset_management APO
$111.48
price up icon 1.85%
Cap:     |  Volume (24h):